(Q54231332)

16 June 2018

title

Momordica charantia constituents and antidiabetic screening of the isolated major compounds. (English)

1 reference

16 June 2018

(1S,4S,5S,8R,9R,12S,13S,16S,19R)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-19-methoxy-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

1 reference

(1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-ol

1 reference

1 reference

1 reference

1 reference

8-(6-Hydroxy-6-methylhept-4-en-2-yl)-19-methoxy-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

1 reference

3beta,7beta,25-Trihydroxycucurbita-5,23-dien-19-al

1 reference

(19R)-19-Methoxy-5beta,19-epoxycucurbita-6,23-diene-3beta,25-diol

1 reference

(1R,4S,5S,8R,9R,12S,13S,16S,19R)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-ene-16,19-diol

1 reference

(23E)-3beta-(beta-D-Allopyranosyloxy)-7beta,25-dihydroxycucurbita-5,23-diene-19-al

1 reference

(1R,3aS,3bR,4S,7S,9aS,9bS,11aR)-4-methoxy-1-[(2R,4E)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1H,2H,3H,3bH,4H,7H,8H,9H,9aH,10H,11H-cyclopenta[a]phenanthren-7-ol

1 reference

17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

8-(6-Methoxy-6-methylhept-4-en-2-yl)-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

1 reference

1 reference

7

Yoshinori Asakawa

1 reference

16 June 2018

author name string

Liva Harinantenaina

1

1 reference

16 June 2018

Michi Tanaka

2

1 reference

16 June 2018

Shigeru Takaoka

3

1 reference

16 June 2018

Munehiro Oda

4

1 reference

16 June 2018

Orie Mogami

5

1 reference

16 June 2018

Masayuki Uchida

6

1 reference

16 June 2018

language of work or name

English

1 reference

Chemical & Pharmaceutical Bulletin

publication date

2006

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb/54/7/54_7_1017/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.54.1017?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

16 June 2018

volume

54

1 reference

16 June 2018

page(s)

1017-1021

1 reference

16 June 2018

issue

7

1 reference

16 June 2018

https://api.unpaywall.org/v2/10.1248/cpb.54.1017?email=unpaywall_01@example.com

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Triterpenes, A sterol and A monocyclic alcohol from Momordica charantia

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

Studies on the constituents of Momordica charantia L. I. Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.28.2753

Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.54

Structures of momordicines I, II and III, the bitter principles in the leaves and vines of Momordica charantia L.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.32.2044

Pharmacological actions and potential uses of Momordica charantia: a review

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

New Cucurbitane Triterpenoids from Momordica charantia

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

Studies on the constituents of Momordica charantia L. II. Isolation and characterization of minor seed glycosides, momordicosides C,D and E.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.29.1561

Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

Cucurbitane triterpenoids from the leaves of Momordica foetida

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1017

Identifiers

DOI

10.1248/CPB.54.1017

1 reference

16 June 2018

PubMed ID

16819222

1 reference

16 June 2018